Murphy, Middleton, Hinkle & Parker, Inc.

Position in NVS — Novartis AG

CIK 1730521 Thomasville, GA

Position in NVS

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$241,348

+$6,113 QoQ

Shares Held

1,540

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.17%

of 13F equity value

Holder Rank

#1,233

of 1,603 holders

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Murphy, Middleton, Hinkle & Parker, Inc. holds $15,661,585 across 8 Drug Manufacturers - General names. NVS ranks #8 (1.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	25,918	$6,582,394
2	LLY	ELI LILLY & Co	3,750	$4,497,862
3	MRK	Merck & Co., Inc.	10,472	$1,345,652
4	AMGN	Amgen Inc	3,661	$1,325,721
5	PFE	Pfizer Inc	33,101	$797,072
6	BMY	Bristol Myers Squibb Co	8,007	$461,363
7	ABBV	AbbVie Inc.	1,630	$410,173
8	NVS	Novartis AG This page	1,540	$241,348

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$241,348	1,540	0.0%	Shares	Sole	2026-07-14
2026-03-31	$235,235	1,540	-18.2%	Shares	Sole	2026-04-15
2024-09-30	$216,467	1,882	-4.3%	Shares	Sole	2024-10-15
2024-06-30	$209,300	1,966	-5.1%	Shares	Sole	2024-07-16
2023-12-31	$209,209	2,072	+4.9%	Shares	Sole	2024-01-24
2023-09-30	$201,173	1,975	-45.3%	Shares	Sole	2023-10-03
2021-03-31	$308,497	3,609	-0.7%	Shares	Sole	2021-04-08
2020-12-31	$343,064	3,633	-2.3%	Shares	Sole	2021-01-12
2020-09-30	$323,317	3,718	0.0%	Shares	Sole	2020-10-13
2020-06-30	$324,730	3,718	0.0%	Shares	Sole	2020-07-08
2020-03-31	$306,549	3,718	—	Shares	Sole	2020-04-09
No filing history on record for this holder in this stock.